Neferine inhibits the development of lung cancer cells by downregulating TGF‐β to regulate MST1/ROS‐induced pyroptosis

Abstract Non‐small cell lung cancer (NSCLC) accounts for ~85% of all lung cancer cases. Neferine is used as a traditional Chinese medicine with many pharmacological effects, including antitumor properties; however, it has not been reported whether neferine plays an anticancer role by causing pyropto...

Full description

Bibliographic Details
Main Authors: Peng‐Cheng Zhong, Zhi‐Wen Liu, Qi‐Chang Xing, Jia Chen, Rui‐Pei Yang
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/kjm2.12752
_version_ 1797633734742114304
author Peng‐Cheng Zhong
Zhi‐Wen Liu
Qi‐Chang Xing
Jia Chen
Rui‐Pei Yang
author_facet Peng‐Cheng Zhong
Zhi‐Wen Liu
Qi‐Chang Xing
Jia Chen
Rui‐Pei Yang
author_sort Peng‐Cheng Zhong
collection DOAJ
description Abstract Non‐small cell lung cancer (NSCLC) accounts for ~85% of all lung cancer cases. Neferine is used as a traditional Chinese medicine with many pharmacological effects, including antitumor properties; however, it has not been reported whether neferine plays an anticancer role by causing pyroptosis in NSCLC cells. We used two typical lung cancer cell lines, A549 and H1299, and 42 lung cancer tissue samples to investigate the regulatory effects of neferine on TGF‐β and MST1. We also treated lung cancer cells with different concentrations of neferine to study its effects on lung cancer cell survival, migration, invasion, and epithelial–mesenchymal transition (EMT) as well as on pyroptosis. Lentivirus‐mediated gain‐of‐function studies of TGF‐β and MST1 were applied to validate the roles of TGF‐β and MST1 in lung cancer. Next, we used murine transplanted tumor models to evaluate the effect of neferine treatment on the metastatic capacity of lung cancer tissues. With increasing neferine concentration, the viability, migration, invasion, and EMT capacity of A549 and H1299 cells decreased, whereas pyroptosis increased. Neferine repressed TGF‐β expression to modulate the induction of reactive oxygen species (ROS) by MST1. Overexpression of TGF‐β in either in vitro or mouse‐transplanted A549 cells restored the inhibitory effect of neferine on tumor development. Overexpression of MST1 clearly enhanced pyroptosis. Neferine contributed to pyroptosis by regulating MST1 expression through downregulation of TGF‐β to induce ROS formation. Therefore, our study shows that neferine can serve as an adjuvant therapy for NSCLC patients.
first_indexed 2024-03-11T11:58:01Z
format Article
id doaj.art-aba3f9192ac840a3be6f2675e349e78b
institution Directory Open Access Journal
issn 1607-551X
2410-8650
language English
last_indexed 2024-03-11T11:58:01Z
publishDate 2023-11-01
publisher Wiley
record_format Article
series Kaohsiung Journal of Medical Sciences
spelling doaj.art-aba3f9192ac840a3be6f2675e349e78b2023-11-08T12:00:32ZengWileyKaohsiung Journal of Medical Sciences1607-551X2410-86502023-11-0139111106111810.1002/kjm2.12752Neferine inhibits the development of lung cancer cells by downregulating TGF‐β to regulate MST1/ROS‐induced pyroptosisPeng‐Cheng Zhong0Zhi‐Wen Liu1Qi‐Chang Xing2Jia Chen3Rui‐Pei Yang4Department of Integrated Traditional Chinese and Western Medicine Xiangtan Central Hospital Xiangtan ChinaResearch Institute for Future Food The Hong Kong Polytechnic University, Hong Kong Special Administrative Region Hong Kong ChinaDepartment of Pharmaceutical Xiangtan Central Hospital Xiangtan ChinaDepartment of Pharmaceutical Xiangtan Central Hospital Xiangtan ChinaLaboratory of Traditional Chinese Medicine, Shenzhen Traditional Chinese Medicine Hospital The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine Shenzhen ChinaAbstract Non‐small cell lung cancer (NSCLC) accounts for ~85% of all lung cancer cases. Neferine is used as a traditional Chinese medicine with many pharmacological effects, including antitumor properties; however, it has not been reported whether neferine plays an anticancer role by causing pyroptosis in NSCLC cells. We used two typical lung cancer cell lines, A549 and H1299, and 42 lung cancer tissue samples to investigate the regulatory effects of neferine on TGF‐β and MST1. We also treated lung cancer cells with different concentrations of neferine to study its effects on lung cancer cell survival, migration, invasion, and epithelial–mesenchymal transition (EMT) as well as on pyroptosis. Lentivirus‐mediated gain‐of‐function studies of TGF‐β and MST1 were applied to validate the roles of TGF‐β and MST1 in lung cancer. Next, we used murine transplanted tumor models to evaluate the effect of neferine treatment on the metastatic capacity of lung cancer tissues. With increasing neferine concentration, the viability, migration, invasion, and EMT capacity of A549 and H1299 cells decreased, whereas pyroptosis increased. Neferine repressed TGF‐β expression to modulate the induction of reactive oxygen species (ROS) by MST1. Overexpression of TGF‐β in either in vitro or mouse‐transplanted A549 cells restored the inhibitory effect of neferine on tumor development. Overexpression of MST1 clearly enhanced pyroptosis. Neferine contributed to pyroptosis by regulating MST1 expression through downregulation of TGF‐β to induce ROS formation. Therefore, our study shows that neferine can serve as an adjuvant therapy for NSCLC patients.https://doi.org/10.1002/kjm2.12752MST1NeferineNSCLCPyroptosisTGF‐β
spellingShingle Peng‐Cheng Zhong
Zhi‐Wen Liu
Qi‐Chang Xing
Jia Chen
Rui‐Pei Yang
Neferine inhibits the development of lung cancer cells by downregulating TGF‐β to regulate MST1/ROS‐induced pyroptosis
Kaohsiung Journal of Medical Sciences
MST1
Neferine
NSCLC
Pyroptosis
TGF‐β
title Neferine inhibits the development of lung cancer cells by downregulating TGF‐β to regulate MST1/ROS‐induced pyroptosis
title_full Neferine inhibits the development of lung cancer cells by downregulating TGF‐β to regulate MST1/ROS‐induced pyroptosis
title_fullStr Neferine inhibits the development of lung cancer cells by downregulating TGF‐β to regulate MST1/ROS‐induced pyroptosis
title_full_unstemmed Neferine inhibits the development of lung cancer cells by downregulating TGF‐β to regulate MST1/ROS‐induced pyroptosis
title_short Neferine inhibits the development of lung cancer cells by downregulating TGF‐β to regulate MST1/ROS‐induced pyroptosis
title_sort neferine inhibits the development of lung cancer cells by downregulating tgf β to regulate mst1 ros induced pyroptosis
topic MST1
Neferine
NSCLC
Pyroptosis
TGF‐β
url https://doi.org/10.1002/kjm2.12752
work_keys_str_mv AT pengchengzhong neferineinhibitsthedevelopmentoflungcancercellsbydownregulatingtgfbtoregulatemst1rosinducedpyroptosis
AT zhiwenliu neferineinhibitsthedevelopmentoflungcancercellsbydownregulatingtgfbtoregulatemst1rosinducedpyroptosis
AT qichangxing neferineinhibitsthedevelopmentoflungcancercellsbydownregulatingtgfbtoregulatemst1rosinducedpyroptosis
AT jiachen neferineinhibitsthedevelopmentoflungcancercellsbydownregulatingtgfbtoregulatemst1rosinducedpyroptosis
AT ruipeiyang neferineinhibitsthedevelopmentoflungcancercellsbydownregulatingtgfbtoregulatemst1rosinducedpyroptosis